Tetramethylbenzidineを用いた培養甲状腺濾胞細胞のPeroxidase活性の測定
スポンサーリンク
概要
- 論文の詳細を見る
Thyroid peroxidase (TPO) is well known to be an essential enzyme for the biosynthesis of thyroid hormone. The changes of TPO activities in thyroid tissue have already been reported in pathophysiological and experimental conditions by several assay methods. Most of these assay methods, however, need relatively large amounts of tissue (over 10mg wet tissue) to obtain enzyme fraction for assay by homogenization and fractionation of the tissue. Therefore, it is difficult to apply these methods to relatively small numbers (less than 10<SUP>6</SUP> cells) of thyroid cells. In the present study, we attempted to develop a new and simple method for the assay of TPO activity using tetramethylbenzidine (TMB) as substrate. The reaction mixture were composed of 250μl of commercially available tetramethylbenzidine solution containing H<SUB>2</SUB>O<SUB>2</SUB> (TM-Blue<SUP>®</SUP>, TSI-CDP) and 250μl of cell lysate obtained by freeze-thawing in 0.1M citrate buffer (pH 4.8). Various doses of known amounts of horseradish peroxidase (HRP; 0-1000μU) were assayed as a standard at the same time. TPO activity in cell lysate was expressed as the activity corresponding to HRP activity. In this assay method, TPO activity of sonicated-cell lysate was higher than that of nonsonicated-cell lysate, and the activity in sonicated cell lysate was linearly correlated with cell numbers. Next, the effects on the TPO activity of the direct addition of various agents into the reaction mixture were also examined. Both methylmercaptoimidazole (MMI) and NaN<SUB>3</SUB> strongly inhibited TPO activity in sonicated-cell lysate as well as in mitochondria-microsomal fraction of thyroid tissue with the respective IC<SUB>50</SUB> value of less than 5μM and less than 0.1mM.<BR>In the present method, the authors could demonstrate the following: 1) After 4 days of suspension culture with TSH (0.5mU/ml), TPO activity of the follicles increased 3.2-5.6 fold when compared with that cultured in the absence of TSH. 2) (Bu)<SUB>2</SUB>cAMP (DBC; 1mM) and forskolin (20μM) also increased TPO activity of the follicles by 2.9-5.2 and by 2.9-6.2 fold. 3) The addition of NaI (0-100μM) into medium dose-dependently inhibited the induction of TPO activity by TSH. 4) EGF (10-8M) and PMA (10-6M) as well as NaI (100μM) also inhibited the induction of TPO activity in the follicles by TSH, DBC and forskolin during culture for 4 days. Accordingly, it is indicated that these agents may inhibit an induction of TPO activity at least in part at the step of post-cAMP.<BR>The present assay method was simple and convenient for assay of TPO activity in a relatively small number of cultured thyroid cells. However, further improvement was needed to obtain a full activity of TPO in the cells because intracellular reducing agents may affect TPO activity in the present method.
- 一般社団法人 日本内分泌学会の論文
著者
関連論文
- 本学における診療参加型臨床実習に関する考察 : モデル・コア・カリキュラムの導入と診療参加型臨床実習のあり方
- バセドウ病と破壊性甲状腺炎の初診時における迅速鑑別法
- 診断ガイドラインの利用と問題点
- PDE-3阻害薬 (糖尿病性細小血管症(第2版)--発症・進展制御の最前線) -- (糖尿病性細小血管症の薬物療法の進歩)
- 甲状腺クリーゼ20 例の治療と予後─甲状腺クリーゼ診断基準を用いた検討─
- キノロン耐性 GBS (Streptococcus agalactiae) による腸腰筋膿瘍を呈した2型糖尿病の1例
- 23.2型糖尿病患者を対象とした自記式質問表(QUEST問診票)による逆流性食道炎・胃食道逆流症の評価とオメプラゾールの効果(一般演題,第34回獨協医学会)
- Angiotensin II 投与による酸化ストレスによって低アディポネクチン血症は惹起される
- 減量効果が肥満患者の血中肥満関連因子(PAI-1, レプチン)と高感度CRPに与える影響
- 16.テトラヒドロビオプテリンのAngiotensin II投与ラットにおけるoxidativestress/nitrosativestressの減弱効果および心血管保護効果(一般演題,第33回 獨協医学会)
- 肥満 : 内分泌代謝的側面
- プロブコール投与が高脂血症を合併した2型糖尿病患者の脂質代謝に及ぼす効果 : 特にMDA-LDLの検討を中心として
- モサプリドが著効を示した1型糖尿病胃腸症の1例 : バリウムマーカー法による検討
- 人間ドック受診男性を対象とした血中コチニン濃度と肥満関連因子との関係
- 糖尿病の著しい増悪の後発見され腫瘍摘出後その寛解が認められた正常血圧性副腎外褐色細胞腫の1例
- 甲状腺全摘出手術後症状が出現した,thyrotropin releasing hormone負荷後growth hormoneの著明な過剰反応を認めた先端巨大症の1例
- 粘液水腫性昏睡/クリーゼ (特集 Emergency実践ガイド) -- (疾患と対応 内分泌・代謝)
- 13.テトラヒドロビオプテリンは動脈硬化を抑制する(一般演題,第35回獨協医学会)
- バセドウ病を合併した機能性甲状腺乳頭癌の1例
- 薬剤誘発性の甲状腺中毒症・甲状腺機能低下症 (特集 潜在性甲状腺疾患--Subclinical hypothyroidismの実態調査と治療手引き)
- 7.アクチンフィラメント形成阻害による血管平滑筋iNOS発現の増強(一般演題,第32回 獨協医学会)
- バセドウ病の治療
- 他の疾患や病態に起因する糖尿病 インスリン抵抗性・耐糖能異常を伴う遺伝性症候群 筋強直性ジストロフィー (新時代の糖尿病学(1)病因・診断・治療研究の進歩) -- (糖尿病基礎研究の進歩 糖尿病と耐糖能低下の成因分類と発症機序)
- ラット心筋細胞における tetrahydrobiopterin 産生の誘導と調節-nitric oxide 産生との関連
- 心血管系に対する PACAP の効果
- 薬剤による甲状腺機能低下症
- 当院における高カルシウム血症の病因・病態の解析と治療 ─高カルシウム血症クリーゼも含めて─
- Tetramethylbenzidineを用いた培養甲状腺濾胞細胞のPeroxidase活性の測定
- 甲状腺髄様癌に血圧正常の褐色細胞腫を合併し、家族歴をみとめず本人が初発と考えられるmultiple endocrine neoplasia type2Aの一例
- 131I-MIBG陽性を示した腎腫瘍の一例
- グルコースによる血管平滑筋細胞におけるPAI-1遺伝子発現の増強
- 2型糖尿病早期におけるリラグルチドの有用性 患者満足度調査も含めて